Proxee vs PollyReach
Side-by-side comparison of features, pros & cons, pricing, and community votes (2026).
🏆 Proxee leads with 0 upvotes
Your localhost on your phone, synced
Proxee is a powerful and innovative tool designed for developers who need seamless mobile UI testing of local web projects. It transforms your phone into a dedicated monitor for local development environments, providing a native, hassle-free experience that surpasses traditional browser emulators. With features like QR pairing, automatic reconnection, bidirectional sync for navigation and theme, SSR-safe proxying, and support for complex auth flows like OAuth redirects, Proxee offers a comprehensive solution for real-device testing. Its framework-agnostic and zero-config setup make it accessible for developers working with various tech stacks, while its native macOS and iOS components ensure smooth, integrated workflows. Overall, Proxee stands out as a reliable, secure, and user-friendly tool that bridges the gap between local development and real device testing, making it ideal for developers, QA teams, and makers focused on mobile-first experiences.
Pros
- Native macOS and iOS apps for seamless integration
- Bidirectional sync for navigation, scrolling, and themes
- SSR-safe proxying and support for complex auth flows
- Zero-configuration setup, framework-agnostic
- Real device testing with a native companion app
Cons
- Limited visibility on user adoption and reviews (ProductHunt votes are zero)
- Potential learning curve for non-technical users
- Pricing details are not explicitly provided, may involve subscription costs
Best for
- • Previewing local web apps on mobile devices during development
- • Testing responsive designs on real iOS devices
- • Debugging mobile-specific issues in local projects
- • Simulating user authentication flows with OAuth redirects
Pricing: Based on its features and target audience, Proxee likely follows a freemium model with a free tier offering basic functionality and paid plans starting around $10-$20/month for advanced features and team usage.
Give your agent a real number and voice to make calls.
PollyReach is an innovative AI-powered telephony tool designed for individual users and small to medium-sized businesses seeking a seamless communication assistant. Unlike traditional enterprise-heavy solutions, PollyReach offers a user-friendly platform where you can assign a real phone number to your AI agent. This agent can handle calls, book reservations, screen spam, and provide detailed reports including call recordings and transcripts. Its ability to operate in over 50 languages makes it accessible globally, and its 24/7 answering capabilities ensure you're always connected without manual intervention. Whether you need it to automate customer interactions, manage personal calls, or handle scheduling, PollyReach simplifies voice communication with a focus on ease of use and versatility. Its unique approach combines natural conversation handling with practical call management, making it ideal for busy individuals and small businesses looking to leverage AI in everyday communication.
Pros
- Provides a real phone number for authentic calling capabilities
- Supports over 50 languages for global usability
- Handles calls, bookings, and spam screening autonomously
- Offers call summaries, recordings, and transcripts for easy review
- Operates 24/7, ensuring continuous availability
Cons
- May have limitations on advanced enterprise integrations
- Pricing details are not explicitly provided, which could impact budgeting
- Dependence on AI accuracy for nuanced conversations
Best for
- • Automating appointment bookings and reservations
- • Handling customer service calls for small businesses
- • Screening and blocking spam or unwanted calls
- • Providing virtual reception for personal or business use
Pricing: Likely follows a freemium model with basic features available for free and premium plans starting around $10-$30 per month, depending on call volume and additional features. Exact pricing details are not publicly confirmed.